Why Understanding the Size of a Benefit Matters: Interpreting Omega-3 Research in Heart and Metabolic Health

When we read about nutrition research, it’s common to focus only on whether a supplement “works.”

What’s equally important—and often overlooked—is how much of an effect was observed.

Without paying attention to the size of the benefit, many supplements can look similar even when their impacts differ substantially.

By law, supplement companies cannot go into details about facts stated within the study.

Regulations are designed to ensure that supplements are not promoted like drugs, and these protections are important for consumers.

At the same time, these rules can limit how much companies are allowed to say about the magnitude of effects reported in published research—even when it is factual.

As a result, consumers may find it harder to compare products or understand how meaningful a study’s findings actually are.

Although the purpose of regulatory bodies is to differentiate supplements from drugs, this gives an opportunity for supplement companies to promote supplements that have little or no health support when we cannot talk about “size of effect.”

As consumers, this makes it even more important to understand the evidence ourselves so we can make informed choices.

Below, we explain why the size of an effect matters, and we use one published randomized controlled trial (RCT) on omega-3 fatty acids as an example.

 

Wait a second…

Before diving into the example study, it’s helpful to briefly review which types of research are most useful when evaluating supplements.

When assessing scientific evidence, the strongest support generally comes from:

• Peer-reviewed clinical studies, which undergo independent scientific evaluation (see our earlier post for a deeper discussion), AND
• Human randomized controlled trials (RCTs) and meta-analyses, which help reduce bias and determine whether an observed effect is likely due to the intervention rather than chance (also covered in more detail in this previous post)

Other types of research—such as cell studies, animal studies, or bioavailability studies—can provide early insights, but they cannot reliably show how much support a nutrient may offer in humans.

 

Example RCT: Omega-3 Fatty Acids and Triglyceride Levels in Healthy Adults

A well-conducted RCT study[1] by Dr. Ann Skulas-Ray and colleagues investigated how different daily servings of omega-3 fatty acids—EPA + DHA (eicosapentaenoic acid + docosahexaenoic acid)—influenced markers of heart and metabolic health in healthy adults with moderately elevated triglyceride (TG) levels.

Who participated? 

• 26 healthy adults (23 men, 3 women)

What was compared?

Daily intake for 8 weeks of:

• 4 grams (g) EPA+DHA
• 85 g EPA+DHA
• A placebo (inactive capsules with 0 g EPA+DHA, designed to look identical to the omega-3 capsules)

What was measured (selected outcomes)?

Researchers examined several outcomes in the study. Key measures included:

• Omega-3 levels in red blood cells (including EPA, DHA, and the “omega-3 index”, a well-established long-term marker of omega-3 status)
• TG levels, one marker related to metabolic health
• LDL-cholesterol (LDL-c; “bad” cholesterol), a commonly monitored blood lipid

Key Findings (Compared to Placebo)

1. Omega-3 levels in red blood cells increased more in people taking the larger daily amount.

• Both daily servings increased EPA, DHA, and the omega-3 index, but the larger serving had the larger effect.

Omega-3 marker*	0.85 g EPA+DHA	3.4 g EPA+DHA
EPA	+102%	+304%
DHA	+22%	+48%
Omega-3 index**	+32%	+79%

*Values relative to placebo

**The combined amount of EPA and DHA (the two main omega-3 fatty acids)

 

2. Only the higher daily serving showed a meaningful, statistically reliable change in TG.

• 4 g/day: 27% change in TG compared to placebo. The statistical test (p < 0.05) suggests this result was unlikely due to chance.
• 85 g/day: A small (9%) change was seen, but the statistical test showed it might be random (p > 0.05). So, the researchers did not view the lower daily amount as having a meaningful effect on TG.

 

3. TG and LDL-c changed in opposite directions.

The study observed an inverse relationship:

• When TG levels decreased, LDL-c tended to increase
• When TG levels increased, LDL-c tended to decrease

This finding illustrates that lipid measurements can sometimes move together in complex ways when omega-3 intake is studied.

This pattern appears in some studies, but not all.

Anyone tracking lipid levels should review their results with a healthcare professional.

 

How Is TG Change Connected to Long-term Health?

TG levels are one of several markers linked to heart health.

High-quality research suggests that the size of TG change is linked to long-term heart health.[2]

That said, heart health depends on many factors, and changes in TG alone do not guarantee specific long-term results.

 

What Can Consumers Take From This?

1. The amount we take can influence the size of benefit

The two daily servings led to:

• Different changes in omega-3 blood levels
• Different effects on TG

This shows that intake level can matter when it comes to measurable biological responses.

 

2. Different study measurements can tell us a completely different story 

Even though both servings raised omega-3 levels in red blood cells, only the higher serving level was associated with a meaningful TG change in this study.

As TG may serve as a more relevant marker for consumers, this highlights the importance of looking closely at different outcomes when interpreting research on daily amounts.

Different measurements can lead to different conclusions — so one result shouldn’t be taken to predict another.

 

3. Consider the full picture of lipid markers

Because TG and LDL-c can shift in opposite directions, anyone using omega-3 supplements for general wellness should monitor both markers and discuss their results with a healthcare provider.

 

4. Time matters

This study lasted 8 weeks.

Longer-term research is needed to understand how different daily servings influence markers over months or years.

 

Final Thoughts

This example illustrates why the size of an effect matters when evaluating supplements.

This single study should not be used alone to make decisions about starting or stopping omega-3 supplementation.

Instead, it should be considered as one data point within a much larger body of research.

We hope this post helps empower consumers to focus on the information that truly matters to them when looking at supplement research.

We will continue to share clear and truthful information about supplements, and we will not stop in our commitment to helping readers better understand the science behind them.

Wishing us all well on our health and learning journeys.

 

Sincerely,

Derek Tang, PhD, MS, BSPharm

Truth Full Health

Your Trusted Supplement Partner

 

*Disclaimer: all blogged content is for informational purposes only and does not replace professional medical advice. The statements made regarding dietary supplements (vitamins and supplements) have not been evaluated by the Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before beginning any new supplement, diet, or health regimen.

 

[1] Title: Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. First author: AC Skulas-Ray. Journal: The American Journal of Clinical Nutrition. Year of publication: 2011.

[2] Title: Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials. First author: NA Marston. Journal: Circulation. Year of publication: 2019.